SILEXION THERAPEUTICS CORP Net Income (Loss) Attributable to Noncontrolling Interest
SILEXION THERAPEUTICS CORP (SLXN) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2025-12-31, per its S-1/A filed 2026-08-10.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-10
- SILEXION THERAPEUTICS CORP net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $0.00.
- SILEXION THERAPEUTICS CORP net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- SILEXION THERAPEUTICS CORP net income (loss) attributable to noncontrolling interest for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- SILEXION THERAPEUTICS CORP net income (loss) attributable to noncontrolling interest for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $0.00 S-1/A · filed 2026-08-10 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $9.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $9.00K derived: sum of 3 quarters · filed 2026-08-10 | $26.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2024-12-31 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $9.00K derived: sum of 2 quarters · filed 2026-08-10 | $26.00K derived: sum of 3 quarters · filed 2026-08-10 | $76.00K S-1/A · filed 2026-08-10 |
| 2024-09-30 | $9.00K 10-Q · filed 2025-11-12 | $26.00K derived: sum of 2 quarters · filed 2025-11-12 | $76.00K 10-Q · filed 2025-11-12 | $28.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $17.00K 10-Q · filed 2025-08-12 | $67.00K 10-Q · filed 2025-08-12 | $19.00K derived: sum of 3 quarters · filed 2025-08-20 | $41.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2024-03-31 | $50.00K 10-Q · filed 2025-05-13 | $2.00K derived: sum of 2 quarters · filed 2025-08-20 | $24.00K derived: sum of 3 quarters · filed 2025-08-20 | $247.00K derived: sum of 4 quarters · filed 2025-08-20 |
| 2023-12-31 | -$48.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-08-20 | -$26.00K derived: sum of 2 quarters · filed 2025-08-20 | $197.00K derived: sum of 3 quarters · filed 2025-08-20 | $166.00K 8-K · filed 2025-08-20 |
| 2023-09-30 | $22.00K 10-Q · filed 2024-11-14 | $245.00K derived: sum of 2 quarters · filed 2024-11-14 | $214.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $223.00K 10-Q · filed 2024-08-29 | $192.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |